Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:23 AM
Ignite Modification Date:
2025-12-25 @ 2:23 AM
NCT ID:
NCT00222534
Eligibility Criteria:
Inclusion Criteria:
* Arterial pO2 8 kPa or lower, and arterial pCO2 7 kPa or higher.
* Base Excess 8 mmmol/l or higher.
* Written informed consent
Exclusion Criteria:
* Acetazolamide treatment regarded as obviously indicated or obviously contraindicated
* Already using acetazolamide
* Moribund patient
* Unable to give fully informed consent
* Allergy towards the tablet content or unable to swallow the tablets
* Pregnant or breast-feeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00222534
Study Brief:
Protocol Section:
NCT00222534